The Institute of Directors on AstraZeneca:

“It is misleading to present AstraZeneca as some kind of UK national champion. The company is a truly multinational enterprise that was created through the earlier mergers of UK, Swedish and American companies. The majority of its employees are based outside Europe and its shareholders are overwhelming foreign institutional investors. It is run by a Frenchman and chaired by a Swede. It is a multinational company active in a global economy.”